FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under ANDA072205. This action represents an approval of a supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)